| 产品详情 |
| Edit |   |
|---|
| Product Name | Ticagrelor |
|---|
| Description | Purity >98%. Ticagrelor is a reversible antagonist of the platelet purinergic P2Y12 receptor (Ki = 14 nM; IC50 = 1.8 µM), which is the main receptor responsible for ADP-induced platelet aggregation. It functions by directly changing the conformation of the P2Y12 receptor to inhibit ADP binding. Ticagrelor has been studied for its application in antiplatelet therapy to prevent ischemic cardiac complications associated with cardiovascular diseases. |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol, AR-C 126532XX, AZD 6140 |
|---|
| Gene, Accession, CAS # | CAS: 274693-27-5 |
|---|
| Catalog # | LS-H10219 |
|---|
| Price | |
|---|
| Order / More Info | Ticagrelor from LIFESPAN BIOSCIENCES INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|